Dec 24, 2024, 11:40
Joshua Brody: Practice-changing ASH24 updates on Follicular Lymphoma Immunotherapy
Joshua Brody, Director of Lymphoma Immunotherapy Program at The Icahn School of Medicine at Mount Sinai, shared on LinkedIn:
“Practice-changing ASH24 updates on Follicular Lymphoma immunotherapy including earlier rx with bispecific Abs and novel combinations from trials and around the world!”
Further Reading:
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 24, 2024, 17:39
Dec 24, 2024, 17:10
Dec 24, 2024, 16:42
Dec 24, 2024, 16:39